Good evening :)
$
₹
P

Psyence Biomedical Ltd. Warrant

PBMWW

NASDAQ
P

Psyence Biomedical Ltd. Warrant

PBMWW

NASDAQ
$0.028.36% (-0.00)
$
₹
$0.028.36% (-0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Unknown

Sector and industry information not available

Unknown

Recent listing (market-cap unavailable as on date)

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

—
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.

Peers

Peers

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Financials

Financials

Income

Balance Sheet

Cash Flow

-24.7
0.1
0.1
-0.7
Q4 2023
Q3 2024
Q4 2024
Q3 2025
Revenue
Net Income
Financial YearQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023Q3 2024Q4 2024Q3 2025
Total Revenue-----0-0-0
Net Income2.040.762.25-0.02-0.06-0.87-24.760.140.14-0.75
Net Profit Margin----------
See CostsAll values in $ Million

Frequently asked questions

  1. Psyence Biomedical Ltd. Warrant (PBMWW) share price today is $0.02 as of September 21, 2026 at 10:33 PM IST. The stock touched a day high of $0.02 and a day low of $0.02.

  2. Psyence Biomedical Ltd. Warrant stock trades on NASDAQ under the ticker symbol PBMWW.

  3. Psyence Biomedical Ltd. Warrant's market capitalization is N/A as of September 21, 2026 at 10:33 PM IST.

  4. Psyence Biomedical Ltd. Warrant's price-to-earnings (P/E) ratio is N/A as of September 22, 2026.

  5. Psyence Biomedical Ltd. Warrant's price-to-book (P/B) ratio is 0 as of September 22, 2026.

  6. Yes, You can buy Psyence Biomedical Ltd. Warrant shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Psyence Biomedical Ltd. Warrant shares in three steps: 1. Search Psyence Biomedical Ltd. Warrant on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Psyence Biomedical Ltd. Warrant trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Psyence Biomedical Ltd. Warrant (PBMWW) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 434.7826 shares at the current price of $0.02.

Loading...